MDCO-216
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MDCO-216, covering 2017-07-13 to 2017-07-13. Get the full timeline:
Most recent: Clinical Trial Update: MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial [Phase 1, Phase 2]